Sprayable TiC MXene hydrogel for wound healing and drug release system.

Hyeongtaek Park, Jeong-Uk Kim, Soojin Kim, Nathaniel S Hwang, Hwan D Kim
Author Information
  1. Hyeongtaek Park: Department of IT Convergence (BK21 FOUR), Korea National University of Transportation, Chungju, 27469, Republic of Korea.
  2. Jeong-Uk Kim: School of Chemical and Biological Engineering, Institute of Chemical Process, Seoul National University, Seoul, 08826, Republic of Korea.
  3. Soojin Kim: Department of IT Convergence (BK21 FOUR), Korea National University of Transportation, Chungju, 27469, Republic of Korea.
  4. Nathaniel S Hwang: School of Chemical and Biological Engineering, Institute of Chemical Process, Seoul National University, Seoul, 08826, Republic of Korea.
  5. Hwan D Kim: Department of IT Convergence (BK21 FOUR), Korea National University of Transportation, Chungju, 27469, Republic of Korea.

Abstract

Wound healing is a critical process that facilitates the body's recovery from injuries and helps prevent infections, thereby maintaining overall tissue and organ functionality. However, delayed wound healing owing to various factors can lead to bacterial infections and secondary complications. In this study, a ciprofloxacin (CIP)-loaded MXene/sodium alginate (SA) hydrogel was fabricated to inhibit bacterial infections and enhance wound healing. The hydrogel was formulated in a sprayable state by blending CIP-loaded MXene (CIP-MX) with SA. This hydrogel was found to exhibit excellent photothermal conversion capability and biocompatibility under near-infrared (NIR) irradiation. In addition, the hydrogel enabled controlled drug release based on NIR irradiation, ultimately enabling improved antibacterial activity. Based on the and experiments, the CIP-loaded MXene/SA hydrogel (CIP-MX@Gel) accelerated wound healing. Overall, the CIP-MX@Gel has excellent potential as an effective wound healing material.

Keywords

References

  1. iScience. 2022 Jun 16;25(7):104619 [PMID: 35789848]
  2. ACS Nano. 2021 Aug 24;15(8):12687-12722 [PMID: 34374515]
  3. Sci Rep. 2022 May 4;12(1):7213 [PMID: 35508533]
  4. Indian J Plast Surg. 2012 May;45(2):220-8 [PMID: 23162220]
  5. Front Bioeng Biotechnol. 2021 Jun 16;9:681501 [PMID: 34222219]
  6. Theranostics. 2018 Oct 5;8(18):5025-5038 [PMID: 30429884]
  7. ACS Nano. 2020 Apr 28;14(4):4523-4535 [PMID: 32191436]
  8. Cell Commun Signal. 2013 Apr 19;11(1):29 [PMID: 23601247]
  9. Pharmaceutics. 2020 Aug 05;12(8): [PMID: 32764269]
  10. Int J Biol Macromol. 2021 Nov 1;190:693-699 [PMID: 34520776]
  11. Sci Rep. 2020 Apr 30;10(1):7342 [PMID: 32355267]
  12. Carbohydr Polym. 2021 Jan 15;252:117145 [PMID: 33183603]
  13. Mol Med Rep. 2016 Oct;14(4):3336-42 [PMID: 27572477]
  14. Carbohydr Polym. 2021 Aug 15;266:118100 [PMID: 34044919]
  15. Exp Cell Res. 2018 Sep 15;370(2):333-342 [PMID: 29964051]
  16. ACS Appl Bio Mater. 2020 Feb 17;3(2):1258-1266 [PMID: 35019326]
  17. Annu Rev Cell Dev Biol. 2007;23:69-92 [PMID: 17474876]
  18. Clin Sci (Lond). 2012 Feb;122(4):143-59 [PMID: 22029668]
  19. Small. 2022 Feb;18(5):e2104368 [PMID: 34821453]
  20. Biomedicines. 2020 Apr 30;8(5): [PMID: 32365896]
  21. Eur Surg Res. 2017;58(1-2):81-94 [PMID: 27974711]
  22. Acta Biomater. 2021 Aug;130:138-148 [PMID: 34082094]
  23. J Control Release. 2015 Feb 10;199:53-62 [PMID: 25499553]
  24. ACS Appl Mater Interfaces. 2022 Mar 9;14(9):11144-11155 [PMID: 35195389]
  25. Adv Drug Deliv Rev. 2019 Jun;146:209-239 [PMID: 30605737]
  26. FASEB J. 1990 Aug;4(11):2860-7 [PMID: 2199284]
  27. Adv Healthc Mater. 2018 May;7(9):e1701394 [PMID: 29405649]
  28. Biomater Sci. 2022 May 31;10(11):2759-2771 [PMID: 35445676]
  29. Biomed Eng Online. 2021 Apr 1;20(1):33 [PMID: 33794899]
  30. Sci Transl Med. 2021 Mar 17;13(585): [PMID: 33731435]
  31. Nano Lett. 2017 Jan 11;17(1):384-391 [PMID: 28026960]
  32. Biotechnol Adv. 2017 Sep;35(5):530-544 [PMID: 28558979]
  33. Wiley Interdiscip Rev Dev Biol. 2018 Mar;7(2): [PMID: 29316315]
  34. Methods. 2001 Dec;25(4):402-8 [PMID: 11846609]
  35. Chem Rev. 2023 Jun 14;123(11):6891-6952 [PMID: 37133878]
  36. J Control Release. 2015 Dec 10;219:119-128 [PMID: 26325405]
  37. Adv Drug Deliv Rev. 2018 Apr;129:169-193 [PMID: 29501700]